Pharmacosmos bets on new subsidiary for product launch in USA

Changing its strategy, Holbæk-based Pharmacosmos has chosen to go independent for the launch of Monoferric in the USA. A new subsidiary company led by a Dane will run the launch.

Photo: Pharmacosmos/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles